HydraFacial Introduces Revolutionary Peptide Booster for Wrinkle Reduction
The Beauty Health Company (NASDAQ: SKIN), the parent company of the renowned brand HydraFacial, has recently announced robust financial results for the second quarter of 2025. The highlight of this announcement was the successful launch of their groundbreaking product – the HydraFillic with Pep9™ Booster. This advanced peptide-infused skin booster marks a significant milestone in the company’s 30-year history.
The HydraFillic with Pep9™ Booster is formulated with a proprietary blend of nine peptides that are clinically proven to:
- Visibly reduce fine lines and wrinkles
- Deeply hydrate the skin
- Strengthen the skin barrier
Clinical trials have shown impressive results, with participants reporting:
- 100% improvement in skin firmness
- 96% enhancement in skin glow
- 93% experience of tighter, smoother skin after just one treatment
“This launch marks a significant milestone for us as we introduce our latest innovation,” stated Marla Beck, CEO of Beauty Health. The booster employs HydraFacial’s signature vortex-fusion technology to effectively deliver peptides to the deeper layers of the skin, where they have the greatest effect. With more than 35,000 HydraFacial devices in use worldwide, this innovation further solidifies the company’s position in the rapidly growing aesthetic treatments market.
Source: BeautyHealth Reports Second Quarter 2025 Financial Results